Anti-CCL2 (Carlumab)-McMMAF Preis auf Anfrage

Produktübersicht

• Artikelname: Anti-CCL2 (Carlumab)-McMMAF Preis auf Anfrage
• Artikelnummer: TGM-T9901A-1087
• Hersteller Artikelnummer: T9901A-1087
• Alternativnummer: TGM-T9901A-1087-1MG,TGM-T9901A-1087-5MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien

Produktbeschreibung

Anti-CCL2 (Carlumab)-McMMAF is an antibody-drug conjugate (ADC) composed of the humanized anti-CCL2 (chemokine ligand 2) antibody Carlumab, linked with the protective group maleimidocaproyl and the tubulin inhibitor MMAF. The cytotoxic molecule and linker in this ADC are McMMAF. Anti-CCL2 (Carlumab)-McMMAF can induce apoptosis and is used in cancer research.

Produkteigenschaften

• Target-Kategorie: CCR|||Antibody-Drug Conjugates (ADCs)|||Apoptosis|||Microtubule Associated